Sosei Group Corporation (4565) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Sosei Group Corporation Company Snapshot

Business Description:

Sosei Group Corporation operates in the Commercial physical research sector. Sosei Group Corporation is a holding company primarily engaged in the biopharmaceutical business. The Company is mainly involved in the research, development and sale of pharmaceutical drugs, including NVA237 and QVA149, used for chronic obstructive pulmonary disease; SO - 1105, used for oral thrush. As of March 31, 2011, the Company had three consolidated subsidiaries. In our complete report available for purchase the company is compared to: DNA Chip Research, Inc., Carna Biosciences Inc and Tella Incorporation.

Sosei Group Corporation

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 120,000
(Figures in Japanese Yen)

1 Week	-0.8%	13 Weeks	-6.2%

4 Weeks	-2.1%	52 Weeks	-17.2%

Sosei Group Corporation Key Data:

Ticker:	4565	Country:	JAPAN

Exchanges:	TYO	Major Industry:	Miscellaneous

		Sub Industry:	Medical Services

2011 Sales	716,573,000 (Year Ending Jan 2012).	Employees:	25

Currency:	Japanese Yen	Market Cap:	14,200,560,000

Fiscal Yr Ends:	March	Shares Outstanding:	118,338

Share Type:	Common	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.